vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and National Bank Holdings Corp (NBHC). Click either name above to swap in a different company.

National Bank Holdings Corp is the larger business by last-quarter revenue ($126.8M vs $121.8M, roughly 1.0× Core Laboratories Inc.). National Bank Holdings Corp runs the higher net margin — 16.4% vs 4.2%, a 12.2% gap on every dollar of revenue. Over the past eight quarters, National Bank Holdings Corp's revenue compounded faster (14.0% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Old National Bank is an American regional bank with nearly 200 retail branches operated by Old National Bancorp and based in Chicago and Evansville, Indiana. With assets at $48.5 billion and 250 banking centers, Old National Bancorp is the largest financial services bank holding company headquartered in Indiana and one of the top 30 banking companies in the U.S. Old National Bank has locations in Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Tennessee, and Wisconsin.

CLB vs NBHC — Head-to-Head

Bigger by revenue
NBHC
NBHC
1.0× larger
NBHC
$126.8M
$121.8M
CLB
Higher net margin
NBHC
NBHC
12.2% more per $
NBHC
16.4%
4.2%
CLB
Faster 2-yr revenue CAGR
NBHC
NBHC
Annualised
NBHC
14.0%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
NBHC
NBHC
Revenue
$121.8M
$126.8M
Net Profit
$5.1M
$20.8M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
16.4%
Revenue YoY
-1.4%
Net Profit YoY
-14.2%
EPS (diluted)
$0.11
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
NBHC
NBHC
Q1 26
$121.8M
$126.8M
Q4 25
$138.3M
$100.6M
Q3 25
$134.5M
$108.9M
Q2 25
$130.2M
$104.5M
Q1 25
$123.6M
$102.1M
Q4 24
$129.2M
$101.3M
Q3 24
$134.4M
$106.0M
Q2 24
$130.6M
$97.6M
Net Profit
CLB
CLB
NBHC
NBHC
Q1 26
$5.1M
$20.8M
Q4 25
$4.9M
$16.0M
Q3 25
$14.2M
$35.3M
Q2 25
$10.6M
$34.0M
Q1 25
$-154.0K
$24.2M
Q4 24
$7.4M
$28.2M
Q3 24
$11.7M
$33.1M
Q2 24
$9.0M
$26.1M
Gross Margin
CLB
CLB
NBHC
NBHC
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
NBHC
NBHC
Q1 26
1.5%
Q4 25
11.5%
19.0%
Q3 25
15.6%
39.6%
Q2 25
11.7%
39.8%
Q1 25
3.6%
29.2%
Q4 24
11.0%
34.3%
Q3 24
14.7%
37.6%
Q2 24
12.3%
32.5%
Net Margin
CLB
CLB
NBHC
NBHC
Q1 26
4.2%
16.4%
Q4 25
3.6%
15.9%
Q3 25
10.6%
32.4%
Q2 25
8.2%
32.6%
Q1 25
-0.1%
23.7%
Q4 24
5.7%
27.8%
Q3 24
8.7%
31.2%
Q2 24
6.9%
26.8%
EPS (diluted)
CLB
CLB
NBHC
NBHC
Q1 26
$0.11
$0.46
Q4 25
$0.11
$0.42
Q3 25
$0.30
$0.92
Q2 25
$0.22
$0.88
Q1 25
$0.00
$0.63
Q4 24
$0.15
$0.72
Q3 24
$0.25
$0.86
Q2 24
$0.19
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
NBHC
NBHC
Cash + ST InvestmentsLiquidity on hand
$22.8M
$472.8M
Total DebtLower is stronger
$202.1M
Stockholders' EquityBook value
$275.1M
$1.7B
Total Assets
$587.7M
$12.6B
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
NBHC
NBHC
Q1 26
$22.8M
$472.8M
Q4 25
$22.7M
$417.1M
Q3 25
$25.6M
$555.6M
Q2 25
$31.2M
$296.5M
Q1 25
$22.1M
$246.3M
Q4 24
$19.2M
$127.8M
Q3 24
$21.5M
$180.8M
Q2 24
$17.7M
$145.0M
Total Debt
CLB
CLB
NBHC
NBHC
Q1 26
$202.1M
Q4 25
$110.3M
$54.5M
Q3 25
$114.1M
$54.7M
Q2 25
$124.6M
$54.4M
Q1 25
$124.4M
$54.6M
Q4 24
$126.1M
$54.5M
Q3 24
$139.9M
$54.4M
Q2 24
$147.6M
$54.4M
Stockholders' Equity
CLB
CLB
NBHC
NBHC
Q1 26
$275.1M
$1.7B
Q4 25
$266.0M
$1.4B
Q3 25
$271.3M
$1.4B
Q2 25
$261.3M
$1.4B
Q1 25
$253.4M
$1.3B
Q4 24
$246.6M
$1.3B
Q3 24
$250.7M
$1.3B
Q2 24
$240.3M
$1.2B
Total Assets
CLB
CLB
NBHC
NBHC
Q1 26
$587.7M
$12.6B
Q4 25
$584.0M
$9.9B
Q3 25
$591.4M
$10.2B
Q2 25
$602.1M
$10.0B
Q1 25
$591.5M
$10.1B
Q4 24
$585.1M
$9.8B
Q3 24
$600.5M
$10.0B
Q2 24
$597.8M
$10.0B
Debt / Equity
CLB
CLB
NBHC
NBHC
Q1 26
0.12×
Q4 25
0.41×
0.04×
Q3 25
0.42×
0.04×
Q2 25
0.48×
0.04×
Q1 25
0.49×
0.04×
Q4 24
0.51×
0.04×
Q3 24
0.56×
0.04×
Q2 24
0.61×
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
NBHC
NBHC
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
NBHC
NBHC
Q1 26
$4.0M
Q4 25
$7.9M
$162.4M
Q3 25
$8.5M
$52.4M
Q2 25
$13.9M
$32.3M
Q1 25
$6.7M
$39.6M
Q4 24
$20.6M
$155.3M
Q3 24
$13.1M
$47.0M
Q2 24
$17.1M
$31.9M
Free Cash Flow
CLB
CLB
NBHC
NBHC
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
NBHC
NBHC
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
NBHC
NBHC
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
NBHC
NBHC
Q1 26
0.77×
Q4 25
1.61×
10.13×
Q3 25
0.60×
1.48×
Q2 25
1.31×
0.95×
Q1 25
1.64×
Q4 24
2.78×
5.51×
Q3 24
1.12×
1.42×
Q2 24
1.90×
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

NBHC
NBHC

Net Interest Income$108.8M86%
Noninterest Income$18.0M14%

Related Comparisons